$SNDL Cashflow Statement | Understand Stock

$SNDL

$1.27 -$0.02 (1.55%) Close

$SNDL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of CAD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss from continuing operations for the period
Net loss for the period
Adjustments for:
Income tax recovery
Interest and fee revenue
Interest and fee income
Change in fair value of biological assets
Change in fair value of inventory sold
Share-based compensation
Depreciation and amortization
Loss on disposition of assets
Inventory impairment and obsolescence
Finance costs, net
Change in estimate of fair value of derivative warrants
Loss on cancellation of contracts
Loss on financial obligation
Unrealized foreign exchange loss
Restructuring costs
Warrants issued for services
Transaction costs
Bargain purchase gain
Asset impairment, net
Share of loss of equity-accounted investees
Other expenses
Gain on disposition of marketable securities
Realized loss on settlement of marketable securities
Unrealized (gain) loss on marketable securities
Proceeds from settlement of marketable securities
Additions to marketable securities
Proceeds from disposal of marketable securities
Income distributions from equity-accounted investees
Interest received

Exercise of cash-settled deferred share units
Change in non-cash working capital
Net cash provided by (used in) operating activities from continuing operations
Net cash provided by operating activities from discontinued operations
Net cash provided by operating activities
Investing activities
Additions to property, plant and equipment
Additions to intangible assets
Changes to investments
Capital refunds (contributions) to equity-accounted investees
Additions to investments
Additions to equity-accounted investees
Principal payments from investments
Proceeds from disposal of investments
Capital refunds from equity-accounted investees
Capital distributions from equity-accounted investees
Proceeds from disposal of property, plant and equipment
Acquisitions, net of cash acquired
Change in non-cash working capital
Net cash used in investing activities from discontinued operations
Net cash provided by investing activities
Financing activities
Proceeds from convertible notes, net of costs
Change in restricted cash
(Repayment) proceeds of long-term debt
Payments on lease liabilities, net
Repurchase of common shares
Proceeds from issuance of shares, net of costs
Issuance of common shares by subsidiaries
Distributions declared by subsidiaries
Proceeds from exercise of derivative warrants
Proceeds from exercise of equity classified warrants
Proceeds from exercise of employee warrants
Repayment of long-term debt
Convertible debenture settlement
Payment on exercise of contingent consideration warrants
Settlement of convertible notes
Settlement of financial obligation
Change in non-cash working capital
Net cash used in financing activities from discontinued operations
Net cash used in financing activities

Effect of exchange rate changes on cash held in foreign currency
Change in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Comments